The quantity and quality of scientific graphs in pharmaceutical advertisements

Richelle J. Cooper, David L. Schriger, Roger C. Wallace, Vladislav J. Mikulich, Michael S. Wilkes

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

We characterized the quantity and quality of graphs in all pharmaceutical advertisements in the 1999 issues of 10 U.S. medical journals. Four hundred eighty-four unique advertisements (of 3,185 total advertisements) contained 836 glossy and 455 small-print pages. Forty-nine percent of glossy page area was nonscientific figures/images, 0.4% tables, and 1.6% scientific graphs (74 graphs in 64 advertisements). All 74 graphs were univariate displays, 4% were distributions, and 4% contained confidence intervals for summary measures. Extraneous decoration (66%) and redundancy (46%) were common. Fifty-eight percent of graphs presented an outcome relevant to the drug's indication. Numeric distortion, specifically prohibited by FDA regulations, occurred in 36% of graphs.

Original languageEnglish (US)
Pages (from-to)294-297
Number of pages4
JournalJournal of General Internal Medicine
Volume18
Issue number4
DOIs
StatePublished - Apr 1 2003

Keywords

  • Advertising standards
  • Drug industry
  • Graphing
  • Medical illustration

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'The quantity and quality of scientific graphs in pharmaceutical advertisements'. Together they form a unique fingerprint.

Cite this